Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI105588

Testosterone and Androstenedione Blood Production Rates in Normal Women and Women with Idiopathic Hirsutism or Polycystic Ovaries

C. Wayne Bardin and Mortimer B. Lipsett

Endocrinology Branch, National Cancer Institute, Bethesda, Md.

†

Address requests for reprints to Dr. C. Wayne Bardin, Endocrinology Branch, National Cancer Institute, Bethesda, Md. 20014.

*

Submitted for publication November 28, 1966; accepted February 2, 1967.

A preliminary report of this work was presented at the Forty-eighth Meeting of the Endocrine Society, June 20, 1966.

Find articles by Bardin, C. in: PubMed | Google Scholar

Endocrinology Branch, National Cancer Institute, Bethesda, Md.

†

Address requests for reprints to Dr. C. Wayne Bardin, Endocrinology Branch, National Cancer Institute, Bethesda, Md. 20014.

*

Submitted for publication November 28, 1966; accepted February 2, 1967.

A preliminary report of this work was presented at the Forty-eighth Meeting of the Endocrine Society, June 20, 1966.

Find articles by Lipsett, M. in: PubMed | Google Scholar

Published May 1, 1967 - More info

Published in Volume 46, Issue 5 on May 1, 1967
J Clin Invest. 1967;46(5):891–902. https://doi.org/10.1172/JCI105588.
© 1967 The American Society for Clinical Investigation
Published May 1, 1967 - Version history
View PDF
Abstract

The average plasma testosterone concentration of women with either hirsutism or polycystic ovaries and hirsutism was higher (p < 0.01) than that of normal women although the ranges overlapped. Testosterone blood production rates averaged 830 ± 120 SE and 1,180 ± 310 SE μg per day in the two groups of hirsute women and 230 ± 33 SE μg per day in normal women. The ranges did not overlap.

The testosterone metabolic clearance rates of hirsute women (1,090 ± 140 SE L per day) and of men (1,240 ± 136 SE L per day) were significantly higher than those of normal women (590 ± 44 SE L per day). These differences persisted when the metabolic clearance rates were corrected for surface area. We suggest that testosterone metabolic clearance rates vary directly with some function of testosterone production.

The mean plasma androstenedione levels (2.8 ± 0.35 SE and 2.8 ± 0.30 SE μg per L) and production rates (6,060 ± 450 SE and 7,360 ± 345 SE μg per day) of the women with hirsutism or polycystic ovaries, respectively, were significantly higher than those of normal women (1.5 ± 0.22 SE μg per L; 3,300 ± 830 SE μg per day). The androstenedione metabolic clearance rates were the same in each group. Plasma androstenedione was the precursor of 49% of plasma testosterone in normal women and of 26% of plasma testosterone in hirsute women. Thus, 74% of the plasma testosterone in these subjects must have been either secreted or derived from a precursor that did not enter the plasma androstenedione pool.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 891
page 891
icon of scanned page 892
page 892
icon of scanned page 893
page 893
icon of scanned page 894
page 894
icon of scanned page 895
page 895
icon of scanned page 896
page 896
icon of scanned page 897
page 897
icon of scanned page 898
page 898
icon of scanned page 899
page 899
icon of scanned page 900
page 900
icon of scanned page 901
page 901
icon of scanned page 902
page 902
Version history
  • Version 1 (May 1, 1967): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts